Pulmonx Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	68.68	53.66	48.42	32.73	32.6	20
Revenue Growth (YoY)	27.98%	10.84%	47.91%	0.42%	62.94%	-
Cost of Revenue	17.92	13.8	12.79	11.53	10.18	7.72
Gross Profit	50.75	39.87	35.63	21.2	22.41	12.29
Selling, General & Admin	94.61	83.11	69.87	46.07	34.2	20.35
Research & Development	18.08	15.4	13.06	7.46	6.05	6.99
Operating Expenses	112.69	98.5	82.93	53.53	40.25	27.34
Operating Income	-61.94	-58.64	-47.3	-32.33	-17.84	-15.05
Interest Expense / Income	3.23	1.07	0.83	3.18	2.32	2.52
Other Expense / Income	-4.9	-1.13	0.19	-3.5	0.19	0.9
Pretax Income	-60.27	-58.57	-48.32	-32.02	-20.34	-18.47
Income Tax	0.57	0.35	0.34	0.21	0.36	0.01
Net Income	-60.84	-58.92	-48.66	-32.23	-20.7	-18.48
Shares Outstanding (Basic)	38	37	36	10	2	2
Shares Outstanding (Diluted)	38	37	36	10	2	2
Shares Change	2.37%	2.68%	254.74%	473.44%	6.05%	-
EPS (Basic)	-1.60	-1.59	-1.35	-3.16	-11.66	-11.03
EPS (Diluted)	-1.60	-1.59	-1.35	-3.16	-11.66	-11.03
Free Cash Flow	-38.42	-46.4	-45.06	-31.54	-21.49	-18.69
Free Cash Flow Per Share	-1.01	-1.25	-1.25	-3.10	-12.10	-11.16
Gross Margin	73.90%	74.29%	73.59%	64.77%	68.77%	61.42%
Operating Margin	-90.19%	-109.27%	-97.70%	-98.77%	-54.73%	-75.24%
Profit Margin	-88.60%	-109.80%	-100.51%	-98.47%	-63.52%	-92.38%
Free Cash Flow Margin	-55.94%	-86.47%	-93.07%	-96.37%	-65.92%	-93.45%
EBITDA	-52.81	-53.49	-44.26	-26.89	-16.82	-15.68
EBITDA Margin	-76.89%	-99.69%	-91.42%	-82.14%	-51.61%	-78.37%
Depreciation & Amortization	4.23	4.01	3.23	1.95	1.2	0.27
EBIT	-57.04	-57.5	-47.49	-28.84	-18.02	-15.95
EBIT Margin	-83.06%	-107.16%	-98.09%	-88.10%	-55.29%	-79.72%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).